세계의 3D 세포배양 시장 예측(-2028년) : 제품별, 용도별, 최종사용자별, 지역별

3D Cell Culture Market by Product (Hydrogels, ECM, Hanging Drop, Bioreactor, Microfluidics, Magnetic Levitation), Application (Cancer, Stem Cell, Tissue Engineering), End User (Pharma, Biotech, Research), Region - Global Forecast to 2028

US $ 4,950 ￦ 6,814,000

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 6,650 ￦ 9,155,000

PDF (5-user License)

PDF 보고서를 동일 사업장에서 5명까지 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 8,150 ￦ 11,220,000

PDF (Corporate License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 이용 인원에 제한은 없으나, 국내에 있는 사업장만 해당되며, 해외 지점 등은 포함되지 않습니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 10,000 ￦ 13,767,000

PDF (Global License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. (100% 자회사는 동일 기업으로 간주됩니다.) 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

세계의 3D 세포배양 시장 규모는 2023년 13억 달러에서 2028년까지 25억 달러에 달하며, 예측 기간 중 CAGR로 14.6%의 성장이 예측됩니다.

3D 세포배양의 채택 증가 및 3D 세포배양 연구에 대한 자금 제공의 증가 등의 요인이 시장 성장을 촉진하고 있습니다.

"약제 클래스별로는 스캐폴드 기반 3D 세포배양 제품 부문이 예측 기간 중 시장에서 가장 높은 성장률을 차지했습니다. "

제품에 기반하여 3D 세포배양 시장은 스캐폴드 기반 3D 세포배양, 스캐폴드 프리 3D 세포배양, 마이크로플루이딕스 기반 3D 세포배양, 자기·바이오 프린트 3D 세포배양으로 구분됩니다. 스캐폴드 기반 3D 세포배양 부문은 2022년에 최대 점유율을 차지했습니다. 다양한 제약 업계에서 하이드로겔 수요의 증가는 스캐폴드 기반 3D 세포배양 시장의 성장에 호영향을 미칠 가능성이 있습니다.

"용도별로는 암·줄기세포 연구 부문이 2022년에 최대 점유율을 차지했습니다. "

용도에 기반하여 시장은 암·줄기세포 연구, Drug Discovery·독성 시험, 조직공학·재생의료로 구분됩니다. 암·줄기세포 부문 연구는 2022년 시장에서 최대의 시장 점유율을 차지하고 있습니다. 암의 유행 및 정부와 민간 부문에 의한 암연구를 향한 현저한 자금 제공 구상이 이 용도 부문의 주요 성장 촉진요인입니다.

"아시아태평양이 보다 빠른 페이스로 성장할 가능성이 있습니다. "

시장은 유럽, 아시아태평양, 북미, 라틴아메리카, 중동 및 아프리카로 구분됩니다. 아시아태평양 시장은 유리한 규제 가이드라인의 존재, 세포배양 기반 백신 제조에 대한 정부 지원, 낮은 제조 비용, 세계 시장 참여 기업의 아시아 신흥 국가에 대한 주목의 증가에 의해 예측 기간 중 가장 성장하는 지역 부문이 될 전망입니다.

세계의 3D 세포배양 시장에 대해 조사분석했으며, 시장 역학, 지역과 부문 분석, 기업 개요 등을 제공하고 있습니다.

목차

제1장 서론

제2장 조사 방법

제3장 주요 요약

제4장 주요 인사이트

• 3D 세포배양 시장의 개요
• 북미 : 3D 세포배양 시장, 제품별, 국가별(2022년)
• 3D 세포배양의 시장 점유율 : 용도별(2023년·2028년)
• 3D 세포배양의 시장 점유율 : 최종사용자별(2022년)
• 3D 세포배양 시장 : 지역적 성장 기회

제5장 시장의 개요

• 서론
• 시장 역학
  • 촉진요인
  • 억제요인
  • 기회
  • 과제
• 범위/시나리오
• 고객의 비즈니스에 영향을 미치는 동향/혼란
• 밸류체인 분석
• 공급망 분석
• 에코시스템 분석
• Porter's Five Forces 분석
• 특허 분석
• 가격 분석
• 기술 분석
• 규제 분석
• 주요 컨퍼런스와 이벤트(2023년)
• 주요 이해관계자와 구입 기준

제6장 3D 세포배양 시장 : 제품별

• 서론
• 스캐폴드 기반 3D 세포배양
• 스캐폴드 프리 3D 세포배양
• 마이크로플루이딕스 기반 3D 세포배양
• 자기·바이오 프린트 3D 세포배양

제7장 3D 세포배양 시장 : 최종사용자별

• 서론
• 제약기업·바이오테크놀러지 기업
• 연구기관
• 화장품 산업
• 기타 최종사용자

제8장 3D 세포배양 시장 : 용도별

• 서론
• 암·줄기세포 연구
• Drug Discovery·독성 시험
• 조직공학·재생의료

제9장 3D 세포배양 시장 : 지역별

• 서론
• 북미
  • 미국
  • 캐나다
  • 북미 : 불황의 영향
• 유럽
  • 독일
  • 영국
  • 프랑스
  • 이탈리아
  • 스페인
  • 기타 유럽
  • 유럽 : 불황의 영향
• 아시아태평양
  • 중국
  • 일본
  • 인도
  • 기타 아시아태평양
  • 아시아태평양 : 불황의 영향
• 라틴아메리카
• 중동 및 아프리카

제10장 경쟁 구도

• 서론
• 주요 기업이 채택한 전략
• 매출 점유율 분석
• 시장 점유율 분석
• 기업의 평가 쿼드런트
• 상위 25사의 경쟁 벤치마킹
• 기업의 평가 쿼드런트 : 신규 기업/중소기업
• 신규 기업/중소기업의 경쟁 벤치마킹
• 경쟁 시나리오와 동향

제11장 기업 개요

• 주요 기업
  • THERMO FISHER SCIENTIFIC, INC.
  • MERCK KGAA
  • CORNING INCORPORATED
  • LONZA
  • TECAN TRADING AG
  • AVANTOR, INC.
  • REPROCELL INC.
  • 3D BIOTEK LLC
  • EMULATE, INC.
  • SYNTHECON, INCORPORATED
  • INSPHERO AG
  • KIRKSTALL LTD.
  • GREINER BIO-ONE INTERNATIONAL GMBH
  • PROMOCELL GMBH
  • UPM BIOMEDICALS
• 기타 기업
  • CN BIO INNOVATIONS LTD.
  • TISSUSE GMBH
  • LENA BIOSCIENCES INC.
  • CELLENDES GMBH
  • ADVANCED BIOMATRIX, INC.(PART OF BICO)
  • SYNVIVO INC.
  • AMSBIO
  • MIMETAS BV
  • S-BIO, VAUPELL HOLDINGS INC.(A GROUP COMPANY OF SUMITOMO BAKELITE CO., LTD. )
  • NANOFIBER SOLUTIONS

제12장 부록

KSA

영문 목차

영문목차

The global 3D cell culture market size is projected to reach USD 2.5 billion by 2028 from USD 1.3 billion in 2023, at a CAGR of 14.6% during the forecast period. Factors such as increased adoption of 3D cell culture coupled with increased funding for 3D cell culture research is driving the market growth.

"The scaffold-based 3D cell culture product segment accounted for the highest growth rate in the 3D cell culture market, by drug class, during the forecast period"

Based on product, the 3D cell culture market is segmented into scaffold-based 3D cell cultures, scaffold-free 3D cell cultures, microfluidics-based 3D cell cultures, and magnetic & bioprinted 3D cell cultures. The scaffold-based 3D cell cultures segment accounted for the largest share in 2022. Rising demand for hydrogels across various pharmaceutical industries is likely to have positive impact on the growth of scaffold-based 3D cell culture market.

"Cancer and Stem cell research segment accounted for the largest share of the application segment in 2022."

Based on application, the market is segmented into cancer & stem cell research, drug discovery & toxicology testing, and tissue engineering & regenerative medicine. Cancer & stem cell segment research accounted for the largest market share in the market in 2022. The increasing prevalence of cancer and significant funding initiatives for cancer research from the government and the private sector are major factors driving the growth of this application segment.

"Asia Pacific region is likely to grow at a faster pace."

The 3D cell culture market is segmented into Europe, Asia Pacific, North America, latin America and Middle East and Africa. The APAC market is expected to be the fastest-growing regional segment during the forecast period due the presence of favorable regulatory guidelines, government support for cell culture-based vaccine production, low manufacturing costs, and the growing focus of global market players on emerging Asian countries.

The primary interviews conducted for this report can be categorized as follows:

• By Respondent: Supply Side- 70%, and Demand Side - 30%
• By Designation (Supply Side): Managers - 45%, CXOs & Directors - 30%, Executives- 25%
• By Region: North America -40%, Europe -25%, Asia-Pacific -20%, Latin America -10%, and Middle East and Africa -5%

Lists of Companies Profiled in the Report:

• Thermo Fisher Scientific, Inc. (US)
• Merck KGaA (Germany)
• Corning Incorporated (US)
• Lonza (Switzerland)
• Tecan Trading AG (Switzerland)
• Avantor, Inc.(US),
• REPROCELL Inc. (Japan)
• 3D Biotek LLC. (US)
• S-BIO, Vaupell Holdings Inc. (US)
• Advanced BioMatrix, Inc. (US)
• UPM Biomedicals (Finland)
• SYNTHECON, INCORPORATED (US)
• InSphero (Switzerland)
• Emulate, Inc. (US)
• CN Bio Innovations Ltd. (UK)
• SynVivo, Inc.(US)
• Kirkstall Ltd. (UK)
• Lena Biosciences (US)
• TissUse GmbH (Germany)
• Cellendes GmbH (Germany)
• Greiner Bio-one International GmbH (Germany)
• AMSBIO (UK)
• MIMETAS B.V.(Netherlands)
• Promocell GmbH (Germany)
• Nanofiber Solutions (US)

Research Coverage:

This report provides a detailed picture of the 3D cell culture market. It aims at estimating the size and future growth potential of the market across different segments, such as product, application, end user and region. The report also includes an in-depth competitive analysis of the key market players, along with their company profiles, recent developments, and key market strategies.

Key Benefits of Buying the Report:

The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall 3D cell culture market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, restraints, opportunities, and challenges.

The report provides insights on the following pointers:

• Analysis of key drivers (high focus on developing alterantives to animal testing, greater adoption of personalized medicine, increased government support and funding, increased academia-research collabrations), restraints (high cost of implementing 3D cell culture technologies, lack of widely accepted or single standardization in 3D cell culture), opportunities (emergence of microfluidic based 3D cell culture), and challenges (lack of consistency in 3D cell culture products, high dependency on plastic waste disposals and consumables) influencing the growth of 3D cell culture market.
• Product Development/Innovation: Detailed insights on newly launched products of the 3D cell culture market.
• Market Development: Comprehensive information about lucrative markets - the report analyses the 3D cell culture market across varied regions.
• Market Diversification: Exhaustive information about new services, untapped geographies, recent developments, and investments in the 3D cell culture market.
• Competitive Assessment: In-depth assessment of market shares, growth strategies and service offerings of leading players . Thermo Fisher Scientific, Inc. (US), Merck KGaA (Germany), Corning Incorporated (US), Lonza (Switzerland), and Avantor Inc. (US) and among others in the 3D cell culture market.

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 STUDY OBJECTIVES
• 1.2 MARKET DEFINITION
  • 1.2.1 INCLUSIONS AND EXCLUSIONS
• 1.3 MARKET SCOPE
  • 1.3.1 MARKETS COVERED
  • 1.3.2 YEARS CONSIDERED
• 1.4 CURRENCY CONSIDERED
• 1.5 RESEARCH LIMITATIONS
• 1.6 STAKEHOLDERS
• 1.7 SUMMARY OF CHANGES
• 1.8 IMPACT OF ECONOMIC RECESSION ON 3D CELL CULTURE MARKET

2 RESEARCH METHODOLOGY

• 2.1 RESEARCH DATA
  • FIGURE 1 RESEARCH DESIGN
  • 2.1.1 SECONDARY DATA
  • 2.1.2 PRIMARY DATA
  • FIGURE 2 3D CELL CULTURE MARKET: BREAKDOWN OF PRIMARIES
• 2.2 MARKET SIZE ESTIMATION
  • FIGURE 3 3D CELL CULTURE MARKET SIZE ESTIMATION (SUPPLY SIDE ANALYSIS), 2022
  • FIGURE 4 MARKET SIZE ESTIMATION: APPROACH 1 (REVENUE SHARE ANALYSIS), 2022
  • FIGURE 5 ILLUSTRATIVE EXAMPLE OF THERMO FISHER SCIENTIFIC, INC.: REVENUE SHARE ANALYSIS, 2022
  • 2.2.1 INSIGHTS FROM PRIMARIES
  • FIGURE 6 MARKET VALIDATION FROM PRIMARY EXPERTS
  • 2.2.2 SEGMENT ASSESSMENT (BY PRODUCT, APPLICATION, AND END USER)
  • FIGURE 7 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
• 2.3 GROWTH RATE ASSUMPTIONS
  • FIGURE 8 3D CELL CULTURE MARKET: CAGR PROJECTIONS, 2023-2028
  • FIGURE 9 3D CELL CULTURE MARKET: GROWTH ANALYSIS OF DRIVERS, RESTRAINTS, CHALLENGES, AND OPPORTUNITIES
• 2.4 MARKET BREAKDOWN AND DATA TRIANGULATION
  • FIGURE 10 DATA TRIANGULATION METHODOLOGY
• 2.5 STUDY ASSUMPTIONS
• 2.6 RISK ANALYSIS
• 2.7 IMPACT OF ECONOMIC RECESSION ON 3D CELL CULTURE MARKET
  • TABLE 1 GLOBAL INFLATION RATE PROJECTIONS, 2024-2028 (% GROWTH)
  • TABLE 2 US HEALTH EXPENDITURE, 2019-2022 (USD MILLION)
  • TABLE 3 US HEALTH EXPENDITURE, 2023-2027 (USD MILLION)

3 EXECUTIVE SUMMARY

• FIGURE 11 3D CELL CULTURE MARKET, BY TYPE, 2023 VS. 2028 (USD MILLION)
• FIGURE 12 3D CELL CULTURE MARKET, BY APPLICATION, 2023 VS. 2028 (USD MILLION)
• FIGURE 13 3D CELL CULTURE MARKET, BY END USER, 2023 VS. 2028 (USD MILLION)
• FIGURE 14 GEOGRAPHICAL SNAPSHOT OF 3D CELL CULTURE MARKET

4 PREMIUM INSIGHTS

• 4.1 3D CELL CULTURE MARKET OVERVIEW
  • FIGURE 15 INCREASED FOCUS ON DEVELOPING ALTERNATIVES TO ANIMAL TESTING TO PROPEL MARKET
• 4.2 NORTH AMERICA: 3D CELL CULTURE MARKET, BY PRODUCT AND COUNTRY (2022)
  • FIGURE 16 SCAFFOLD-BASED 3D CELL CULTURES ACCOUNTED FOR LARGEST SHARE OF NORTH AMERICAN 3D CELL CULTURE MARKET IN 2022
• 4.3 3D CELL CULTURE MARKET SHARE, BY APPLICATION, 2023 VS. 2028
  • FIGURE 17 CANCER & STEM CELL RESEARCH TO DOMINATE MARKET IN 2028
• 4.4 3D CELL CULTURE MARKET SHARE, BY END USER, 2022 (USD MILLION)
  • FIGURE 18 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES DOMINATED 3D CELL CULTURE MARKET IN 2022
• 4.5 3D CELL CULTURE MARKET: GEOGRAPHICAL GROWTH OPPORTUNITIES
  • FIGURE 19 ASIA PACIFIC TO REGISTER HIGHEST GROWTH RATE FROM 2023 TO 2028

5 MARKET OVERVIEW

• 5.1 INTRODUCTION
• 5.2 MARKET DYNAMICS
  • FIGURE 20 3D CELL CULTURE MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • TABLE 4 3D CELL CULTURE MARKET: IMPACT ANALYSIS
  • 5.2.1 DRIVERS
    • 5.2.1.1 High focus on developing alternatives to animal testing
    • 5.2.1.2 Greater adoption of personalized medicine globally for multiple diseases
    • 5.2.1.3 Increased government support and funding for 3D cell culture
    • 5.2.1.4 Increased industry-academia collaboration on 3D cell culture and research
  • 5.2.2 RESTRAINTS
    • 5.2.2.1 High costs of implementing 3D cell culture technologies
    • 5.2.2.2 Lack of widely accepted or single standardization in 3D cell culture
  • 5.2.3 OPPORTUNITIES
    • 5.2.3.1 Emergence of microfluidics-based 3D cell culture
    • 5.2.3.2 High growth opportunities and booming biopharmaceutical sector in emerging economies
  • 5.2.4 CHALLENGES
    • 5.2.4.1 Lack of consistency in 3D cell culture products
    • 5.2.4.2 High dependence on plastic waste disposals and consumables
  • TABLE 5 COMPARISON OF SINGLE-USE BIOPROCESSING SYSTEM DISPOSAL OPTIONS
• 5.3 RANGES/SCENARIOS
  • FIGURE 21 SCENARIOS BASED ON IMPACT OF UNCERTAINTIES ON GROWTH OF 3D CELL CULTURE MARKET
• 5.4 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
• 5.5 VALUE CHAIN ANALYSIS
  • FIGURE 22 VALUE CHAIN ANALYSIS OF 3D CELL CULTURE MARKET: RAW MATERIAL AND MANUFACTURING PHASE ADD MAXIMUM VALUE
• 5.6 SUPPLY CHAIN ANALYSIS
  • FIGURE 23 3D CELL CULTURE MARKET: SUPPLY CHAIN ANALYSIS
• 5.7 ECOSYSTEM ANALYSIS
  • FIGURE 24 ECOSYSTEM ANALYSIS: 3D CELL CULTURE MARKET
  • TABLE 6 3D CELL CULTURE MARKET: ROLE IN ECOSYSTEM
• 5.8 PORTER'S FIVE FORCES ANALYSIS
  • TABLE 7 3D CELL CULTURE MARKET: PORTER'S FIVE FORCES ANALYSIS
  • 5.8.1 THREAT OF NEW ENTRANTS
  • 5.8.2 THREAT OF SUBSTITUTES
  • 5.8.3 BARGAINING POWER OF SUPPLIERS
  • 5.8.4 BARGAINING POWER OF BUYERS
  • 5.8.5 INTENSITY OF COMPETITIVE RIVALRY
• 5.9 PATENT ANALYSIS
  • 5.9.1 LIST OF MAJOR PATENTS
• 5.10 PRICING ANALYSIS
  • TABLE 8 SELLING PRICE OF 3D CELL CULTURE PRODUCTS BY TOP PLAYERS (2022)
  • TABLE 9 AVERAGE SELLING PRICE, BY APPLICATION (2022)
• 5.11 TECHNOLOGY ANALYSIS
  • TABLE 10 ADVANTAGES AND DISADVANTAGES OF 3D CELL CULTURE TECHNIQUES
• 5.12 REGULATORY ANALYSIS
  • 5.12.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 11 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 12 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 13 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 14 REST OF THE WORLD: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
• 5.13 KEY CONFERENCES AND EVENTS IN 2023
  • TABLE 15 3D CELL CULTURE MARKET: DETAILED LIST OF CONFERENCES AND EVENTS IN 2023
• 5.14 KEY STAKEHOLDERS AND BUYING CRITERIA
  • 5.14.1 KEY STAKEHOLDERS IN BUYING PROCESS
  • FIGURE 25 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF 3D CELL CULTURE PRODUCTS
  • 5.14.2 BUYING CRITERIA
  • FIGURE 26 KEY BUYING CRITERIA FOR END USERS

6 3D CELL CULTURE MARKET, BY PRODUCT

• 6.1 INTRODUCTION
  • TABLE 16 3D CELL CULTURE MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
• 6.2 SCAFFOLD-BASED 3D CELL CULTURES
  • TABLE 17 3D CELL CULTURE MARKET FOR SCAFFOLD-BASED 3D CELL CULTURES, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 18 3D CELL CULTURE MARKET FOR SCAFFOLD-BASED 3D CELL CULTURES, BY REGION, 2021-2028 (USD MILLION)
  • TABLE 19 NORTH AMERICA: 3D CELL CULTURE MARKET FOR SCAFFOLD-BASED 3D CELL CULTURES, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 20 EUROPE: 3D CELL CULTURE MARKET FOR SCAFFOLD-BASED 3D CELL CULTURES, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 21 ASIA PACIFIC: 3D CELL CULTURE MARKET FOR SCAFFOLD-BASED 3D CELL CULTURES, BY COUNTRY, 2021-2028 (USD MILLION)
  • 6.2.1 HYDROGELS/ECM ANALOGS
    • 6.2.1.1 Hydrogels/ECM analogs to dominate scaffold-based 3D cell cultures market during forecast period
  • TABLE 22 HYDROGELS/ECM ANALOGS MARKET, BY REGION, 2021-2028 (USD MILLION)
  • TABLE 23 NORTH AMERICA: HYDROGELS/ECM ANALOGS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 24 EUROPE: HYDROGELS/ECM ANALOGS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 25 ASIA PACIFIC: HYDROGELS/ECM ANALOGS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • 6.2.2 NATURAL & SYNTHETIC HYDROGELS
    • 6.2.2.1 Easy synthetization on large scale and improved control of matrix architecture to propel segment
  • TABLE 26 HYDROGELS/ECM ANALOGS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • 6.2.3 SOLID SCAFFOLDS
    • 6.2.3.1 Solid scaffolds to be widely adopted in regenerative medicine and preclinical in-vitro testing
  • TABLE 27 SOLID SCAFFOLDS MARKET, BY REGION, 2021-2028 (USD MILLION)
  • TABLE 28 NORTH AMERICA: SOLID SCAFFOLDS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 29 EUROPE: SOLID SCAFFOLDS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 30 ASIA PACIFIC: SOLID SCAFFOLDS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • 6.2.4 MICROPATTERNED SURFACES
    • 6.2.4.1 Micropatterned surfaces to enhance expression of enzyme levels and drug reactivity
  • TABLE 31 MICROPATTERNED SURFACES MARKET, BY REGION, 2021-2028 (USD MILLION)
  • TABLE 32 NORTH AMERICA: MICROPATTERNED SURFACES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 33 EUROPE: MICROPATTERNED SURFACES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 34 ASIA PACIFIC: MICROPATTERNED SURFACES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
• 6.3 SCAFFOLD-FREE 3D CELL CULTURES
  • TABLE 35 3D CELL CULTURE MARKET FOR SCAFFOLD-FREE 3D CELL CULTURES, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 36 3D CELL CULTURE MARKET FOR SCAFFOLD-FREE 3D CELL CULTURES, BY REGION, 2021-2028 (USD MILLION)
  • TABLE 37 NORTH AMERICA: 3D CELL CULTURE MARKET FOR SCAFFOLD-FREE 3D CELL CULTURES, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 38 EUROPE: 3D CELL CULTURE MARKET FOR SCAFFOLD-FREE 3D CELL CULTURES, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 39 ASIA PACIFIC: 3D CELL CULTURE MARKET FOR SCAFFOLD-FREE 3D CELL CULTURES, BY COUNTRY, 2021-2028 (USD MILLION)
  • 6.3.1 LOW ATTACHMENT PLATES
    • 6.3.1.1 Low attachment plates to grow at highest rate in scaffold-free 3D cell cultures market
  • TABLE 40 LOW ATTACHMENT PLATES MARKET, BY REGION, 2021-2028 (USD MILLION)
  • TABLE 41 NORTH AMERICA: LOW ATTACHMENT PLATES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 42 EUROPE: LOW ATTACHMENT PLATES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 43 ASIA PACIFIC: LOW ATTACHMENT PLATES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • 6.3.2 HANGING DROP PLATES
    • 6.3.2.1 Hanging drop plates to be mostly used in stem cell differentiation and cytotoxicity research
  • TABLE 44 HANGING DROP PLATES MARKET, BY REGION, 2021-2028 (USD MILLION)
  • TABLE 45 NORTH AMERICA: HANGING DROP PLATES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 46 EUROPE: HANGING DROP PLATES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 47 ASIA PACIFIC: HANGING DROP PLATES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • 6.3.3 3D BIOREACTORS
    • 6.3.3.1 3D bioreactors to be commonly used in mass production of cells
  • TABLE 48 3D BIOREACTORS MARKET, BY REGION, 2021-2028 (USD MILLION)
  • TABLE 49 NORTH AMERICA: 3D BIOREACTORS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 50 EUROPE: 3D BIOREACTORS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 51 ASIA PACIFIC: 3D BIOREACTORS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • 6.3.4 3D PETRI DISHES
    • 6.3.4.1 Europe to witness highest growth in 3D Petri dishes during study period
  • TABLE 52 3D PETRI DISHES MARKET, BY REGION, 2021-2028 (USD MILLION)
  • TABLE 53 NORTH AMERICA: 3D PETRI DISHES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 54 EUROPE: 3D PETRI DISHES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 55 ASIA PACIFIC: 3D PETRI DISHES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
• 6.4 MICROFLUIDICS-BASED 3D CELL CULTURES
  • 6.4.1 MICROFLUIDICS-BASED 3D CELL CULTURES TO GROW AT HIGHEST RATE DURING FORECAST PERIOD
  • TABLE 56 3D CELL CULTURE MARKET FOR MICROFLUIDICS-BASED 3D CELL CULTURES, BY REGION, 2021-2028 (USD MILLION)
  • TABLE 57 NORTH AMERICA: 3D CELL CULTURE MARKET FOR MICROFLUIDICS-BASED 3D CELL CULTURES, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 58 EUROPE: 3D CELL CULTURE MARKET FOR MICROFLUIDICS-BASED 3D CELL CULTURES, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 59 ASIA PACIFIC: 3D CELL CULTURE MARKET FOR 3D MICROFLUIDICS-BASED 3D CELL CULTURES, BY COUNTRY, 2021-2028 (USD MILLION)
• 6.5 MAGNETIC & BIOPRINTED 3D CELL CULTURES
  • 6.5.1 3D CELL CULTURE TO BE FORMED WITHOUT MEDIA IN MAGNETIC LEVITATION
  • TABLE 60 3D CELL CULTURE MARKET FOR MAGNETIC & BIOPRINTED 3D CELL CULTURES, BY REGION, 2021-2028 (USD MILLION)
  • TABLE 61 NORTH AMERICA: 3D CELL CULTURE MARKET FOR MAGNETIC & BIOPRINTED 3D CELL CULTURES, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 62 EUROPE: 3D CELL CULTURE MARKET FOR MAGNETIC & BIOPRINTED 3D CELL CULTURES, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 63 ASIA PACIFIC: 3D CELL CULTURE MARKET FOR MAGNETIC & BIOPRINTED 3D CELL CULTURES, BY COUNTRY, 2021-2028 (USD MILLION)

7 3D CELL CULTURE MARKET, BY END USER

• 7.1 INTRODUCTION
  • TABLE 64 3D CELL CULTURE MARKET, BY END USER, 2021-2028 (USD MILLION)
• 7.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
  • 7.2.1 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES TO BE LARGEST END USERS OF 3D CELL CULTURE PRODUCTS
  • TABLE 65 3D CELL CULTURE MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2021-2028 (USD MILLION)
  • TABLE 66 NORTH AMERICA: 3D CELL CULTURE MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 67 EUROPE: 3D CELL CULTURE MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 68 ASIA PACIFIC: 3D CELL CULTURE MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021-2028 (USD MILLION)
• 7.3 RESEARCH INSTITUTES
  • 7.3.1 INCREASED GOVERNMENT FUNDING FOR RESEARCH AND HIGH PREVALENCE OF CANCER TO AUGMENT MARKET
  • TABLE 69 3D CELL CULTURE MARKET FOR RESEARCH INSTITUTES, BY REGION, 2021-2028 (USD MILLION)
  • TABLE 70 NORTH AMERICA: 3D CELL CULTURE MARKET FOR RESEARCH INSTITUTES, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 71 EUROPE: 3D CELL CULTURE MARKET FOR RESEARCH INSTITUTES, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 72 ASIA PACIFIC: 3D CELL CULTURE MARKET FOR RESEARCH INSTITUTES, BY COUNTRY, 2021-2028 (USD MILLION)
• 7.4 COSMETICS INDUSTRY
  • 7.4.1 FOCUS ON DEVELOPING ALTERNATIVES FOR ANIMAL TESTING TO FUEL MARKET
  • TABLE 73 3D CELL CULTURE MARKET FOR COSMETICS INDUSTRY, BY REGION, 2021-2028 (USD MILLION)
  • TABLE 74 NORTH AMERICA: 3D CELL CULTURE MARKET FOR COSMETICS INDUSTRY, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 75 EUROPE: 3D CELL CULTURE MARKET FOR COSMETICS INDUSTRY, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 76 ASIA PACIFIC: 3D CELL CULTURE MARKET FOR COSMETICS INDUSTRY, BY COUNTRY, 2021-2028 (USD MILLION)
• 7.5 OTHER END USERS
  • TABLE 77 3D CELL CULTURE MARKET FOR OTHER END USERS, BY REGION, 2021-2028 (USD MILLION)
  • TABLE 78 NORTH AMERICA: 3D CELL CULTURE MARKET FOR OTHER END USERS, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 79 EUROPE: 3D CELL CULTURE MARKET FOR OTHER END USERS, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 80 ASIA PACIFIC: 3D CELL CULTURE MARKET FOR OTHER END USERS, BY COUNTRY, 2021-2028 (USD MILLION)

8 3D CELL CULTURE MARKET, BY APPLICATION

• 8.1 INTRODUCTION
  • TABLE 81 3D CELL CULTURE MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
• 8.2 CANCER & STEM CELL RESEARCH
  • 8.2.1 RISING PREVALENCE OF CANCER AND OTHER COMPLEX DISEASES GLOBALLY TO PROPEL MARKET
  • TABLE 82 3D CELL CULTURE MARKET FOR CANCER & STEM CELL RESEARCH, BY REGION, 2021-2028 (USD MILLION)
  • TABLE 83 NORTH AMERICA: 3D CELL CULTURE MARKET FOR CANCER & STEM CELL RESEARCH, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 84 EUROPE: 3D CELL CULTURE MARKET FOR CANCER & STEM CELL RESEARCH, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 85 ASIA PACIFIC: 3D CELL CULTURE MARKET FOR CANCER & STEM CELL RESEARCH, BY COUNTRY, 2021-2028 (USD MILLION)
• 8.3 DRUG DISCOVERY & TOXICOLOGY TESTING
  • 8.3.1 INCREASED ADOPTION OF PERSONALIZED MEDICINES AND EXPANSION OF PHARMACEUTICAL COMPANIES TO SUPPORT MARKET
  • TABLE 86 3D CELL CULTURE MARKET FOR DRUG DISCOVERY & TOXICOLOGY TESTING, BY REGION, 2021-2028 (USD MILLION)
  • TABLE 87 NORTH AMERICA: 3D CELL CULTURE MARKET FOR DRUG DISCOVERY & TOXICOLOGY TESTING, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 88 EUROPE: 3D CELL CULTURE MARKET FOR DRUG DISCOVERY & TOXICOLOGY TESTING, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 89 ASIA PACIFIC: 3D CELL CULTURE MARKET FOR DRUG DISCOVERY & TOXICOLOGY TESTING, BY COUNTRY, 2021-2028 (USD MILLION)
• 8.4 TISSUE ENGINEERING & REGENERATIVE MEDICINE
  • 8.4.1 INCREASING RESEARCH ON 3D CULTURE TECHNIQUES TO AID MARKET
  • TABLE 90 3D CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY REGION, 2021-2028 (USD MILLION)
  • TABLE 91 NORTH AMERICA: 3D CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 92 EUROPE: 3D CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 93 ASIA PACIFIC: 3D CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY COUNTRY, 2021-2028 (USD MILLION)

9 3D CELL CULTURE MARKET, BY REGION

• 9.1 INTRODUCTION
  • TABLE 94 3D CELL CULTURE MARKET, BY REGION, 2021-2028 (USD MILLION)
• 9.2 NORTH AMERICA
  • FIGURE 27 NORTH AMERICA: 3D CELL CULTURE MARKET SNAPSHOT
  • TABLE 95 NORTH AMERICA: 3D CELL CULTURE MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 96 NORTH AMERICA: 3D CELL CULTURE MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 97 NORTH AMERICA: 3D CELL CULTURE MARKET FOR SCAFFOLD-BASED 3D CELL CULTURES, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 98 NORTH AMERICA: 3D CELL CULTURE MARKET FOR SCAFFOLD-FREE 3D CELL CULTURES, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 99 NORTH AMERICA: 3D CELL CULTURE MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 100 NORTH AMERICA: 3D CELL CULTURE MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 9.2.1 US
    • 9.2.1.1 Adoption of innovative techniques and government-funded initiatives to drive market
  • TABLE 101 US: 3D CELL CULTURE MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 102 US: 3D CELL CULTURE MARKET FOR SCAFFOLD-BASED 3D CELL CULTURES, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 103 US: 3D CELL CULTURE MARKET FOR SCAFFOLD-FREE 3D CELL CULTURES, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 104 US: 3D CELL CULTURE MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 105 US: 3D CELL CULTURE MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 9.2.2 CANADA
    • 9.2.2.1 Advancements in regenerative medicine to boost market
  • TABLE 106 CANADA: 3D CELL CULTURE MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 107 CANADA: 3D CELL CULTURE MARKET FOR SCAFFOLD-BASED 3D CELL CULTURES, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 108 CANADA: 3D CELL CULTURE MARKET FOR SCAFFOLD-FREE 3D CELL CULTURES, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 109 CANADA: 3D CELL CULTURE MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 110 CANADA: 3D CELL CULTURE MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 9.2.3 NORTH AMERICA: RECESSION IMPACT
• 9.3 EUROPE
  • TABLE 111 EUROPE: 3D CELL CULTURE MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 112 EUROPE: 3D CELL CULTURE MARKET FOR SCAFFOLD-BASED 3D CELL CULTURES, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 113 EUROPE: 3D CELL CULTURE MARKET FOR SCAFFOLD-FREE 3D CELL CULTURES, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 114 EUROPE: 3D CELL CULTURE MARKET FOR SCAFFOLD-FREE 3D CELL CULTURES, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 115 EUROPE: 3D CELL CULTURE MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 116 EUROPE: 3D CELL CULTURE MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 9.3.1 GERMANY
    • 9.3.1.1 Spike in investments by key players and growing funding from government organizations to fuel market
  • TABLE 117 GERMANY: 3D CELL CULTURE MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 118 GERMANY: 3D CELL CULTURE MARKET FOR SCAFFOLD-BASED 3D CELL CULTURES, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 119 GERMANY: 3D CELL CULTURE MARKET FOR SCAFFOLD-FREE 3D CELL CULTURES, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 120 GERMANY: 3D CELL CULTURE MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 121 GERMANY: 3D CELL CULTURE MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 9.3.2 UK
    • 9.3.2.1 Growth in life sciences industry to drive market
  • TABLE 122 UK: 3D CELL CULTURE MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 123 UK: 3D CELL CULTURE MARKET FOR SCAFFOLD-BASED 3D CELL CULTURES, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 124 UK: 3D CELL CULTURE MARKET FOR SCAFFOLD-FREE 3D CELL CULTURES, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 125 UK: 3D CELL CULTURE MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 126 UK: 3D CELL CULTURE MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 9.3.3 FRANCE
    • 9.3.3.1 Growth in biotechnology industry to propel market
  • TABLE 127 FRANCE: 3D CELL CULTURE MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 128 FRANCE: 3D CELL CULTURE MARKET FOR SCAFFOLD-BASED 3D CELL CULTURES, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 129 FRANCE: 3D CELL CULTURE MARKET FOR SCAFFOLD-FREE 3D CELL CULTURES, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 130 FRANCE: 3D CELL CULTURE MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 131 FRANCE: 3D CELL CULTURE MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 9.3.4 ITALY
    • 9.3.4.1 Increase in research activities and funds to boost market
  • TABLE 132 ITALY: 3D CELL CULTURE MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 133 ITALY: 3D CELL CULTURE MARKET FOR SCAFFOLD-BASED 3D CELL CULTURES, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 134 ITALY: 3D CELL CULTURE MARKET FOR SCAFFOLD-FREE 3D CELL CULTURES, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 135 ITALY: 3D CELL CULTURE MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 136 ITALY: 3D CELL CULTURE MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 9.3.5 SPAIN
    • 9.3.5.1 Increased collaborations in research and focus on personalized medicine to drive market
  • TABLE 137 SPAIN: 3D CELL CULTURE MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 138 SPAIN: 3D CELL CULTURE MARKET FOR SCAFFOLD-BASED 3D CELL CULTURES, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 139 SPAIN: 3D CELL CULTURE MARKET FOR SCAFFOLD-FREE 3D CELL CULTURES, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 140 SPAIN: 3D CELL CULTURE MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 141 SPAIN: 3D CELL CULTURE MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 9.3.6 REST OF EUROPE
  • TABLE 142 REST OF EUROPE: 3D CELL CULTURE MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 143 REST OF EUROPE: 3D CELL CULTURE MARKET FOR SCAFFOLD-BASED 3D CELL CULTURES MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 144 REST OF EUROPE: 3D CELL CULTURE MARKET FOR SCAFFOLD-FREE 3D CELL CULTURES, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 145 REST OF EUROPE: 3D CELL CULTURE MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 146 REST OF EUROPE: 3D CELL CULTURE MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 9.3.7 EUROPE: RECESSION IMPACT
• 9.4 ASIA PACIFIC
  • FIGURE 28 ASIA PACIFIC: 3D CELL CULTURE MARKET SNAPSHOT
  • TABLE 147 ASIA PACIFIC: 3D CELL CULTURE MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 148 ASIA PACIFIC: 3D CELL CULTURE MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 149 ASIA PACIFIC: 3D CELL CULTURE MARKET FOR SCAFFOLD-BASED 3D CELL CULTURES, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 150 ASIA PACIFIC: 3D CELL CULTURE MARKET FOR SCAFFOLD-FREE 3D CELL CULTURES, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 151 ASIA PACIFIC: 3D CELL CULTURE MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 152 ASIA PACIFIC: 3D CELL CULTURE MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 9.4.1 CHINA
    • 9.4.1.1 Government support and strategic initiatives by key players to strengthen use of biotechnology
  • TABLE 153 CHINA: 3D CELL CULTURE MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 154 CHINA: 3D CELL CULTURE MARKET FOR SCAFFOLD-BASED 3D CELL CULTURES, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 155 CHINA: 3D CELL CULTURE MARKET FOR SCAFFOLD-FREE 3D CELL CULTURES, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 156 CHINA: 3D CELL CULTURE MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 157 CHINA: 3D CELL CULTURE MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 9.4.2 JAPAN
    • 9.4.2.1 Rising prevalence of cancer and increased adoption of 3D cell culture to augment market growth
  • TABLE 158 JAPAN: 3D CELL CULTURE MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 159 JAPAN: 3D CELL CULTURE MARKET FOR SCAFFOLD-BASED 3D CELL CULTURES, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 160 JAPAN: 3D CELL CULTURE MARKET FOR SCAFFOLD-FREE 3D CELL CULTURES, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 161 JAPAN: 3D CELL CULTURE MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 162 JAPAN: 3D CELL CULTURE MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 9.4.3 INDIA
    • 9.4.3.1 Growth in life sciences industry to support market
  • TABLE 163 INDIA: 3D CELL CULTURE MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 164 INDIA: 3D CELL CULTURE MARKET FOR SCAFFOLD-BASED 3D CELL CULTURES, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 165 INDIA: 3D CELL CULTURE MARKET FOR SCAFFOLD-FREE 3D CELL CULTURES, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 166 INDIA: 3D CELL CULTURE MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 167 INDIA: 3D CELL CULTURE MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 9.4.4 REST OF ASIA PACIFIC
  • TABLE 168 REST OF ASIA PACIFIC: 3D CELL CULTURE MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • 9.4.5 ASIA PACIFIC: RECESSION IMPACT
  • TABLE 169 REST OF ASIA PACIFIC: 3D CELL CULTURE MARKET FOR SCAFFOLD-BASED 3D CELL CULTURES, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 170 REST OF ASIA PACIFIC: 3D CELL CULTURE MARKET FOR SCAFFOLD-FREE 3D CELL CULTURES, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 171 REST OF ASIA PACIFIC: 3D CELL CULTURE MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 172 REST OF ASIA PACIFIC: 3D CELL CULTURE MARKET, BY END USER, 2021-2028 (USD MILLION)
• 9.5 LATIN AMERICA
  • 9.5.1 GROWING GOVERNMENT INVESTMENTS AND AVAILABILITY OF GRANTS FOR CELL-BASED RESEARCH TO DRIVE MARKET
  • TABLE 173 LATIN AMERICA: 3D CELL CULTURE MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 174 LATIN AMERICA: 3D CELL CULTURE MARKET FOR SCAFFOLD-BASED 3D CELL CULTURES, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 175 LATIN AMERICA: 3D CELL CULTURE MARKET FOR SCAFFOLD-FREE 3D CELL CULTURES, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 176 LATIN AMERICA: 3D CELL CULTURE MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 177 LATIN AMERICA: 3D CELL CULTURE MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 9.5.2 LATIN AMERICA: RECESSION IMPACT
• 9.6 MIDDLE EAST & AFRICA
  • 9.6.1 INCREASED FUNDING INITIATIVES AND STRATEGIC PARTNERSHIPS IN RESEARCH TO AID MARKET
  • TABLE 178 MIDDLE EAST & AFRICA: 3D CELL CULTURE MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 179 MIDDLE EAST & AFRICA: 3D CELL CULTURE MARKET FOR SCAFFOLD-BASED 3D CELL CULTURES, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 180 MIDDLE EAST & AFRICA: 3D CELL CULTURE MARKET FOR SCAFFOLD-FREE 3D CELL CULTURES, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 181 MIDDLE EAST & AFRICA: 3D CELL CULTURE MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 182 MIDDLE EAST & AFRICA: 3D CELL CULTURE MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 9.6.2 MIDDLE EAST & AFRICA: RECESSION IMPACT

10 COMPETITIVE LANDSCAPE

• 10.1 INTRODUCTION
• 10.2 STRATEGIES ADOPTED BY KEY PLAYERS
  • FIGURE 29 3D CELL CULTURE MARKET: STRATEGIES ADOPTED BY KEY PLAYERS
• 10.3 REVENUE SHARE ANALYSIS
  • FIGURE 30 REVENUE ANALYSIS OF KEY PLAYERS, 2020-2022
• 10.4 MARKET SHARE ANALYSIS
  • FIGURE 31 3D CELL CULTURE MARKET: MARKET SHARE ANALYSIS OF KEY PLAYERS, 2022
  • TABLE 183 3D CELL CULTURE MARKET: DEGREE OF COMPETITION
• 10.5 COMPANY EVALUATION QUADRANT
  • 10.5.1 STARS
  • 10.5.2 EMERGING LEADERS
  • 10.5.3 PERVASIVE PLAYERS
  • 10.5.4 PARTICIPANTS
  • FIGURE 32 3D CELL CULTURE MARKET: COMPANY EVALUATION MATRIX FOR KEY PLAYERS, 2022
• 10.6 COMPETITIVE BENCHMARKING OF TOP 25 PLAYERS
  • 10.6.1 PRODUCT FOOTPRINT OF COMPANIES (25 COMPANIES)
  • TABLE 184 3D CELL CULTURE MARKET: COMPANY PRODUCT FOOTPRINT ANALYSIS OF KEY PLAYERS
  • 10.6.2 REGIONAL FOOTPRINT OF COMPANIES (25 COMPANIES)
  • TABLE 185 3D CELL CULTURE MARKET: REGIONAL FOOTPRINT ANALYSIS OF KEY PLAYERS
• 10.7 COMPANY EVALUATION QUADRANT: START-UPS/SMES
  • 10.7.1 PROGRESSIVE COMPANIES
  • 10.7.2 STARTING BLOCKS
  • 10.7.3 RESPONSIVE COMPANIES
  • 10.7.4 DYNAMIC COMPANIES
  • FIGURE 33 3D CELL CULTURE MARKET: COMPANY EVALUATION MATRIX FOR START-UPS/SMES, 2022
• 10.8 COMPETITIVE BENCHMARKING OF START-UP/SME PLAYERS
  • TABLE 186 3D CELL CULTURE MARKET: DETAILED LIST OF KEY START-UP/SME PLAYERS
  • TABLE 187 3D CELL CULTURE MARKET: COMPETITIVE BENCHMARKING OF START-UPS/SME PLAYERS
• 10.9 COMPETITIVE SCENARIOS AND TRENDS
  • 10.9.1 PRODUCT LAUNCHES
  • TABLE 188 3D CELL CULTURE MARKET: PRODUCT LAUNCHES, JANUARY 2020-APRIL 2023
  • 10.9.2 DEALS
  • TABLE 189 3D CELL CULTURE MARKET: DEALS, JANUARY 2020-APRIL 2023
  • 10.9.3 OTHER DEVELOPMENTS
  • TABLE 190 3D CELL CULTURE MARKET: OTHER DEVELOPMENTS, JANUARY 2020-APRIL 2023

11 COMPANY PROFILES

• 11.1 KEY PLAYERS
• (Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments)**
• 11.1.1 THERMO FISHER SCIENTIFIC, INC.
• TABLE 191 THERMO FISHER SCIENTIFIC, INC.: COMPANY OVERVIEW
• FIGURE 34 THERMO FISHER SCIENTIFIC, INC.: COMPANY SNAPSHOT (2022)
• 11.1.2 MERCK KGAA
• TABLE 192 MERCK KGAA: COMPANY OVERVIEW
• FIGURE 35 MERCK KGAA: COMPANY SNAPSHOT (2022)
• 11.1.3 CORNING INCORPORATED
• TABLE 193 CORNING INCORPORATED: COMPANY OVERVIEW
• FIGURE 36 CORNING INCORPORATED: COMPANY SNAPSHOT (2022)
• 11.1.4 LONZA
• TABLE 194 LONZA: COMPANY OVERVIEW
• FIGURE 37 LONZA: COMPANY SNAPSHOT (2022)
• 11.1.5 TECAN TRADING AG
• TABLE 195 TECAN TRADING AG: COMPANY OVERVIEW
• FIGURE 38 TECAN TRADING AG: COMPANY SNAPSHOT (2022)
• 11.1.6 AVANTOR, INC.
• TABLE 196 AVANTOR, INC.: COMPANY OVERVIEW
• FIGURE 39 AVANTOR, INC: COMPANY SNAPSHOT (2022)
• 11.1.7 REPROCELL INC.
• TABLE 197 REPROCELL: COMPANY OVERVIEW
• 11.1.8 3D BIOTEK LLC
• TABLE 198 3D BIOTEK LLC: COMPANY OVERVIEW
• 11.1.9 EMULATE, INC.
• TABLE 199 EMULATE, INC.: COMPANY OVERVIEW
• 11.1.10 SYNTHECON, INCORPORATED
• TABLE 200 SYNTHECON, INCORPORATED: COMPANY OVERVIEW
• 11.1.11 INSPHERO AG
• TABLE 201 INSPHERO AG: COMPANY OVERVIEW
• 11.1.12 KIRKSTALL LTD.
• TABLE 202 KIRKSTALL LTD.: COMPANY OVERVIEW
• 11.1.13 GREINER BIO-ONE INTERNATIONAL GMBH
• TABLE 203 GREINER BIO-ONE INTERNATIONAL GMBH: COMPANY OVERVIEW
• 11.1.14 PROMOCELL GMBH
• TABLE 204 PROMOCELL GMBH: COMPANY OVERVIEW
• 11.1.15 UPM BIOMEDICALS
• TABLE 205 UPM: COMPANY OVERVIEW
• *Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments might not be captured in case of unlisted companies.
• 11.2 OTHER PLAYERS
  • 11.2.1 CN BIO INNOVATIONS LTD.
  • 11.2.2 TISSUSE GMBH
  • 11.2.3 LENA BIOSCIENCES INC.
  • 11.2.4 CELLENDES GMBH
  • 11.2.5 ADVANCED BIOMATRIX, INC. (PART OF BICO)
  • 11.2.6 SYNVIVO INC.
  • 11.2.7 AMSBIO
  • 11.2.8 MIMETAS BV
  • 11.2.9 S-BIO, VAUPELL HOLDINGS INC. (A GROUP COMPANY OF SUMITOMO BAKELITE CO., LTD.)
  • 11.2.10 NANOFIBER SOLUTIONS

12 APPENDIX

• 12.1 DISCUSSION GUIDE
• 12.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
• 12.3 CUSTOMIZATION OPTIONS
• 12.4 RELATED REPORTS
• 12.5 AUTHOR DETAILS

관련자료